Product Program year 2023 Source: CMS Open Payments

Quadracel

Biological Vaccines

NDC 49281-562-10

Open in the dashboard

General payments

$168,788

9,299 payments

Research payments

$0

0 payments

Through program year 2023, $168,788 in general payments and $0 in research payments were reported against Quadracel (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2023 General $5,814 295
2022 General $94,991 5,058
2021 General $39,872 2,330
2020 General $28,111 1,616

Breakdown

Who paid General payments · program years 2020–2023
  1. Sanofi Pasteur Inc. $168,788 9,299 payments
Top recipients General payments · program year 2023
  1. Francis Voegele Family Medicine · Delaware, OH $43 <1% · 2 payments
  2. Gerald Kremer Family Medicine · Delaware, OH $43 <1% · 2 payments
  3. Kevin Haney Family Medicine · Delaware, OH $43 <1% · 2 payments
  4. Kevin Norowitz Adolescent Medicine · Brooklyn, NY $32 <1% · 1 payment
  5. Yitzchok Norowitz Pediatrics · Brooklyn, NY $32 <1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Pediatrics $2,699 48% · 136 practitioners
  2. Family Medicine $729 13% · 35 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $713 13% · 36 practitioners
  4. Nurse Practitioner, Pediatrics Nurse Practitioner $533 9% · 28 practitioners
  5. Physician Assistant $256 5% · 13 practitioners

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Ohio $932 16% · 41 recipients
  2. Virginia $590 10% · 31 recipients
  3. Michigan $490 8% · 27 recipients
  4. Texas $427 7% · 22 recipients
  5. Arkansas $363 6% · 20 recipients

The top 5 of 26 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

9,299 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record